Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer.
- DOI
- 10.1016/j.eclinm.2026.104199
- Published
- 2026 Oct
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2026.104199,
title = {Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer.},
author = {Hulskotte LMG and Veerman GDM and Lanser DAC and Reyners AKL and van Schaik RHN and Dingemans AC and Taxis K and Mathijssen RHJ and Jansman FGA},
year = {2026},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2026.104199},
url = {https://doi.org/10.1016/j.eclinm.2026.104199}
}RIS
TY - JOUR TI - Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer. AU - Hulskotte LMG AU - Veerman GDM AU - Lanser DAC AU - Reyners AKL AU - van Schaik RHN AU - Dingemans AC AU - Taxis K AU - Mathijssen RHJ AU - Jansman FGA PY - 2026 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2026.104199 UR - https://doi.org/10.1016/j.eclinm.2026.104199 ER -
APA
LMG, H., GDM, V., DAC, L., AKL, R., RHN, V. S., AC, D., K, T., RHJ, M., & FGA, J. (2026). Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104199
Source records
- pubmed · retrieved 2026-09-25T10:50:01.883Z